未登录

黄传钟 (Chuanzhong Huang)

fujian cancer hospital

H指数:13

被引数:438

个人简介

任职于福建医科大学，博士，副主任技师。本科毕业于厦门大学化学系，硕士毕业于厦门大学生物系，博士毕业于福建医科大学免疫学系。主要研究内容包括肝癌转移机制探讨；转录因子在肿瘤放射敏感性中的作用机制研究；肿瘤泛素化与去泛素化药物筛选研究；表观遗传学在肿瘤免疫逃逸中的机制探讨。现为中国抗癌协会肿瘤胃肠病学专委会委员、福建省实验动物学会青委会常务委员、福建省药理学会肿瘤药理专委会委员等。主持5项省级科研项目，以第一作者或通讯作者在国内外学术期刊发表论文20多篇。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

科技进步二等奖（2023）｜福建省抗癌协会
优秀论文三等奖（2024）｜中国抗癌协会

Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer

NF-κB/ALDH1A1信号通路的激活促进非小细胞肺癌对EGFR-TKIs的非突变性耐药

IF7.3

2026-07-230

PRE

ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion

ID3通过重塑MYC来增强PD-L1表达，以促进结直肠癌免疫逃逸。

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2025-04-100

OA

EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway

ANNALS OF HEPATOLOGY

IF4.4

2025-01-010

OAAI

UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation

UBE2T通过PBX1泛素化和PBX1/RORA调控促进I期肺腺癌进展

IF3.4

2024-09-180

OAAI

Targeting Nuclear Receptor Coactivator SRC-1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD-L1

靶向核受体辅激活因子SRC-1通过降低PD-L1的转录和蛋白稳定性预防结直肠癌免疫逃逸

ADVANCED SCIENCE

IF14.1

2024-07-023

OA

Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer (Vol 24, 39, 2024)

IF3.4

2024-03-251

OAAI

A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

基于阿帕替尼的方案在转移性三阴性乳腺癌中的有效性和安全性的真实世界研究

IF3.4

2024-01-054

OAAI

A positive feedback loop between ID3 and PPARγ via DNA damage repair regulates the efficacy of radiotherapy for rectal cancer

IF3.4

2023-05-112

OAAI

Set2 family regulates mycotoxin metabolism and virulence via H3K36 methylation in pathogenic fungus Aspergillus flavus

IF5.4

2022-08-0913

OAAI

EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized Lesions

JOURNAL OF CANCER

IF3.2

2019-01-0118

OAAI

Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats

SCIENTIFIC REPORTS

IF3.9

2017-11-137

OAAI

Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention

SCIENTIFIC REPORTS

IF3.9

2016-03-0228

OAAI

siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells

ONCOLOGY REPORTS

IF3.9

2016-02-0130

OAAI

Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer

IMMUNOLOGIC RESEARCH

IF3.1

2015-11-2529

PREAI

Inhibitor of DNA-binding protein 1 knockdown arrests the growth of colorectal cancer cells and suppresses hepatic metastasis in vivo

ONCOLOGY REPORTS

IF3.9

2014-05-0822

OAAI

Re-irradiation Treatment in 168 Cases Recurrent T1-2 Nasopharyngeal Carcinoma

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2013-10-010

PREAI